Kymera Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $13M | 512k | 25.46 |
| 2023-09-30 | $8.6M | 622k | 13.90 |
| 2023-06-30 | $15M | 656k | 22.99 |
| 2023-03-31 | $17M | 567k | 29.63 |
| 2022-12-31 | $14M | 552k | 24.96 |
| 2022-06-30 | $12M | 603k | 19.69 |
| 2022-03-31 | $6.9M | 164k | 42.31 |
| 2021-12-31 | $12M | 181k | 63.49 |
| 2021-03-31 | $2.3M | 59k | 38.86 |
| 2020-12-31 | $1.2M | 22k | 53.57 |